PiB fails to map amyloid deposits in cerebral cortex of aged dogs with canine cognitive dysfunction

Frontiers in Aging Neuroscience

Volumn 5, Issue DEC, 2013, Pages

  Fast, Rikke ^a   Rodell, Anders ^b,c   Gjedde, Albert ^a,b,c   Mouridsen, Kim ^b   Alstrup, Aage K ^c   Bjarkam, Carsten R ^c,d   West, Mark J ^d   Berendt, Mette ^a   Møller, Arne ^b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

6E10 immunohistochemistry; Alzheimer's disease; Beta amyloid; Canine cognitive dysfunction; Dog; Pittsburgh compound B

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PITTSBURGH COMPOUND B;

AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN MAPPING; BRAIN SCINTISCANNING; CEREBELLUM; COGNITIVE DEFECT; CONTROLLED STUDY; EXPERIMENTAL DOG; FEMALE; FRONTAL CORTEX; GRAY MATTER; HISTOLOGY; MALE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PARIETAL CORTEX; PROTEIN LOCALIZATION; PURKINJE CELL; TEMPORAL CORTEX; WHITE MATTER;

EID: 84895813945     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00099     Document Type: Article

References (54)

1. Aho, L., Pikkarainen, M., Hiltunen, M., Leinonen, V., and Alafuzoff, I. (2010). Immunohistochemical visualization of amyloid-beta protein precursor and amyloid-beta in extra-and intracellular compartments in the human brain. J. Alzheimers Dis. 20, 1015-1028. doi: 10.3233/JAD-2010-091681.
2. Andersen, F., Watanabe, H., Bjarkam, C., Danielsen, E. H., and Cumming, P. (2005). Pig brain stereotaxic standard space: mapping of cerebral blood flow normative values and effect of MPTP-lesioning. Brain Res. Bull. 66, 17-29. doi:10.1016/j.brainresbull.2005.02.033.
3. Anderson, A. J., Ruehl, W. W., Fleischmann, L. K., Stenstrom, K., Entriken, T. L., and Cummings, B. J. (2000). DNA damage and apoptosis in the aged canine brain: relationship to A beta deposition in the absence of neuritic pathology. Prog. Neuropsychopharmacol. Biol. Psychiatry 24, 787-799. doi:10.1016/S0278-5846(00)00106-8.
4. Bacskai, B. J., Frosch, M. P., Freeman, S. H., Raymond, S. B., Augustinack, J. C., Johnson, K. A., et al. (2007). Molecular imaging with Pittsburgh compound B confirmed at autopsy: a case report. Arch. Neurol. 64, 431-434. doi:10.1001/archneur.64.3.431.
5. Bjarkam, C. R., Pedersen, M., and Sorensen, J. C. (2001). New strategies for embedding, orientation and sectioning of small brain specimens enable direct correlation to MR-images, brain atlases, or use of unbiased stereology. J. Neurosci. Methods 108, 153-159. doi:10.1016/S0165-0270(01)00383-1.
6. Blomquist, G., Engler, H., Nordberg, A., Ringheim, A., Wall, A., Forsberg, A., et al. (2008). Unidirectional influx and net accumulation of PIB. Open Neuroimag. J. 2, 114-125. doi:10.2174/1874440000802010114.
7. Cocosco, C. A., Zijdenbos, A. P., and Evans, A. C. (2003). A fully automatic and robust brain MRI tissue classification method. Med. Image Anal. 7, 513-527. doi:10.1016/S1361-8415(03)00037-9.
8. Colle, M. A., Hauw, J. J., Crespeau, F., Uchihara, T., Akiyama, H., Checler, F., et al. (2000). Vascular and parenchymal A beta deposition in the aging dog: correlation with behavior. Neurobiol. Aging 21, 695-704. doi:10.1016/S0197-4580(00)00113-5.
9. Collins, D. L., Neelin, P., Peters, T. M., and Evans, A. C. (1994). Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr. 18, 192-205.
10. Cummings, B. J., Satou, T., Head, E., Milgram, N. W., Cole, G. M., Savage, M. J., et al. (1996). Diffuse plaques contain C-terminal A beta(42) and not A beta(40): evidence from cats and dogs. Neurobiol. Aging 17, 653-659. doi:10.1016/S0197-4580(96)00062-0.
11. Cummings, B. J., Su, J. H., Cotman, C. W., White, R., and Russell, M. J. (1993). Beta-amyloid accumulation in aged canine brain-a model of early plaque-formation in Alzheimer's-disease. Neurobiol. Aging 14, 547-560. doi:10.1016/0197-4580(93)90038-D.
12. Dua-Sharma, S., Jacobs, H. L., and Sharma, K. N. (1970). The Canine Brain in Stereotaxic Coordinates Full Sections in Frontal, Sagittal, and Horizontal Planes. Cambridge, MA: MIT Press.
13. Edison, P., Hinz, R., Ramlackhansingh, A., Thomas, J., Gelosa, G., Archer, H. A., et al. (2012). Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans? Neuroimage 60, 1716-1723. doi:10.1016/j.neuroimage.2012.01.099.
14. Ghiso, J., and Frangione, B. (2001). Cerebral amyloidosis, amyloid angiopathy, and their relationship to stroke and dementia. J. Alzheimers Dis. 3, 65-73.
15. Gjedde, A., Aanerud, J., Braendgaard, H., and Rodell, A. B. (2013). Blood-brain transfer of Pittsburgh compound B in humans. Front. Aging Neurosci. 5:70. doi:10.3389/fnagi.2013.00070.
16. Gulyas, B., Spenger, C., Beliczai, Z., Gulya, K., Kasa, P., Jahan, M., et al. (2012). Distribution and binding of 18F-labeled and 125I-labeled analogues of ACI-80, a prospective molecular imaging biomarker of disease: a whole hemisphere post mortem autoradiography study in human brains obtained from Alzheimer's disease patients. Neurochem. Int. 60, 153-162. doi:10.1016/j.neuint.2011.10.010.
17. Hardy, J., and Selkoe, D. J. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. doi:10.1126/science.1072994.
18. Head, E., Callahan, H., Muggenburg, B. A., Cotman, C. W., and Milgram, N. W. (1998). Visual-discrimination learning ability and beta-amyloid accumulation in the dog. Neurobiol. Aging 19, 415-425. doi:10.1016/S0197-4580(98)00084-0.
19. Head, E., Pop, V., Vasilevko, V., Hill, M., Saing, T., Sarsoza, F., et al. (2008). A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta. J. Neurosci. 28, 3555-3566. doi:10.1523/JNEUROSCI.0208-08.2008.
20. Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., et al. (2008). Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 131, 1630-1645. doi:10.1093/brain/awn016.
21. Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., et al. (2010). Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128. doi:10.1016/S1474-4422(09)70299-6.
22. Kiatipattanasakul, W., Nakamura, S., Hossain, M. M., Nakayama, H., Uchino, T., Shumiya, S., et al. (1996). Apoptosis in the aged dog brain. Acta Neuropathol. 92, 242-248. doi:10.1007/s004010050514.
23. Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., et al. (2004). Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann. Neurol. 55, 306-319. doi:10.1002/ana.20009.
24. Klunk, W. E., Lopresti, B. J., Ikonomovic, M. D., Lefterov, I. M., Koldamova, R. P., Abrahamson, E. E., et al. (2005a). Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J. Neurosci. 25, 10598-10606. doi:10.1523/JNEUROSCI.2990-05.2005.
25. Klunk, W. E., Lopresti, B. J., Ikonomovic, M. D., Lefterov, I. M., Koldamova, R. P., Abrahamson, E. E., et al. (2005b). Binding of the positron emission tomography tracer Pittsburgh compound-B reflects the amount of amyloid-beta in Alzheimer's disease brain but not in transgenic mouse brain. J. Neurosci. 25, 10598-10606. doi:10.1523/JNEUROSCI.2990-05.2005.
26. Klunk, W. E., Price, J. C., Mathis, C. A., Tsopelas, N. D., Lopresti, B. J., Ziolko, S. K., et al. (2007). Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J. Neurosci. 27, 6174-6184. doi:10.1523/JNEUROSCI.0730-07.2007.
27. Klunk, W. E., Wang, Y., Huang, G. F., Debnath, M. L., Holt, D. P., Shao, L., et al. (2003). The binding of 2-(4'-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J. Neurosci. 23, 2086-2092.
28. Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., et al. (2007). PIB is a non-specific imaging marker of amyloid-beta Abeta peptide-related cerebral amyloidosis. Brain 130, 2607-2615. doi:10.1093/brain/awm191.
29. Maes, F., Collignon, A., Vandermeulen, D., Marchal, G., and Suetens, P. (1997). Multimodality image registration by maximization of mutual information. IEEE Trans. Med. Imaging 16, 187-198. doi:10.1109/42.563664.
30. Manook, A., Yousefi, B. H., Willuweit, A., Platzer, S., Reder, S., Voss, A., et al. (2012). Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP/PS1 mouse model of Alzheimer's disease. PLoS ONE 7:e31310. doi:10.1371/journal.pone.0031310.
31. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, J., Kawas, C. H., et al. (2011). The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 263-269. doi:10.1016/j.jalz.2011.03.005.
32. Mintun, M. A., Larossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., et al. (2006). [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67, 446-452. doi:10.1212/01.wnl.0000228230.26044.a4.
33. Moller, M., Rodell, A., and Gjedde, A. (2009). Parametric mapping of 5HT1A receptor sites in the human brain with the Hypotime method: theory and normal values. J. Nucl. Med. 50, 1229-1236. doi:10.2967/jnumed.108.053322.
34. Nielsen, M. S., Bjarkam, C. R., Sorensen, J. C., Bojsen-Moller, M., Sunde, N. A., and Ostergaard, K. (2007). Chronic subthalamic high-frequency deep brain stimulation in Parkinson's disease-a histopathological study. Eur. J. Neurol. 14, 132-138. doi:10.1111/j.1468-1331.2006.01569.x.
35. Osella, M. C., Re, G., Odore, R., Girardi, C., Badino, P., Barbero, R., et al. (2007). Canine cognitive dysfunction syndrome: prevalence, clinical signs and treatment with a neuroprotective nutraceutical. Appl. Anim. Behav. Sci. 105, 297-310. doi:10.1016/j.applanim.2006.11.007.
36. Price, J. C., Klunk, W. E., Lopresti, B. J., Lu, X., Hoge, J. A., Ziolko, S. K., et al. (2005). Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh compound-B. J. Cereb. Blood Flow Metab. 25, 1528-1547. doi:10.1038/sj.jcbfm.9600146.
37. Pugliese, M., Geloso, M. C., Carrasco, J. L., Mascort, J., Michetti, F., and Mahy, N. (2006a). Canine cognitive deficit correlates with diffuse plaque maturation and S100 beta (-) astrocytosis but not with insulin cerebrospinal fluid level. Acta. Neuropathol. 111, 519-528. doi:10.1007/s00401-006-0052-1.
38. Pugliese, M., Mascort, J., Mahy, N., and Ferrer, I. (2006b). Diffuse beta-amyloid plaques and hyperphosphorylated tau are unrelated processes in aged dogs with behavioral deficits. Acta Neuropathol. 112, 175-183. doi:10.1007/s00401-006-0087-3.
39. Rodell, A., Aanerud, J., Braendgaard, H., and Gjedde, A. (2013). Washout allometric reference method (WARM) for parametric analysis of [11C]PIB in human brains. Front. Aging Neurosci. 5:45. doi:10.3389/fnagi.2013.00045.
40. Rofina, J. E., van Ederen, A. M., Toussaint, M. J. M., Secreve, M., van der Spek, A., van der Meer, I., et al. (2006). Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease. Brain Res. 1069, 216-226. doi:10.1016/j.brainres.2005.11.021.
41. Rosen, R. F., Ciliax, B. J., Wingo, T. S., Gearing, M., Dooyema, J., Lah, J. J., et al. (2010). Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease. Acta Neuropathol. 119, 221-233. doi:10.1007/s00401-009-0583-3.
42. Rosen, R. F., Farberg, A. S., Gearing, M., Dooyema, J., Long, P. M., Anderson, D. C., et al. (2008). Tauopathy with paired helical filaments in an aged chimpanzee. J. Comp. Neurol. 509, 259-270. doi:10.1002/cne.21744.
43. Rosen, R. F., Walker, L. C., and Levine, H. III (2011). PIB binding in aged primate brain: enrichment of high-affinity sites in humans with Alzheimer's disease. Neurobiol. Aging 32, 223-234. doi:10.1016/j.neurobiolaging.2009.02.011.
44. Sarasa, L., Gallego, C., Monleón, I., Olvera, A., Canudas, J., Montañés, M., et al. (2010). Cloning, sequencing and expression in the dog of the main amyloid precursor protein isoforms and some of the enzymes related with their processing. Neuroscience 171, 1091-1101. doi:10.1016/j.neuroscience.2010.09.042.
45. Satou, T., Cummings, B. J., Head, E., Nielson, K. A., Hahn, F. F., Milgram, N. W., et al. (1997). The progression of beta-amyloid deposition in the frontal cortex of the aged canine. Brain Res. 774, 35-43. doi:10.1016/S0006-8993(97)81684-8.
46. Sled, J. G., Zijdenbos, A. P., and Evans, A. C. (1998). A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 17, 87-97. doi:10.1109/42.668698.
47. Sorensen, J. C., Bjarkam, C. R., Danielsen, E. H., Simonsen, C. Z., and Geneser, F. A. (2000). Oriented sectioning of irregular tissue blocks in relation to computerized scanning modalities: results from the domestic pig brain. J. Neurosci. Methods 104, 93-98. doi:10.1016/S0165-0270(00)00330-7.
48. Toyama, H., Ye, D., Ichise, M., Liow, J.-S., Cai, L., Jacobowitz, D., et al. (2005). PET imaging of brain with the beta-amyloid probe, 11C6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 32, 593-600. doi:10.1007/s00259-005-1780-5.
49. Uchida, K., Tani, Y., Uetsuka, K., Nakayama, H., and Goto, N. (1992). Immunohistochemical studies on canine cerebral amyloid angiopathy and senile plaques. J. Vet. Med. Sci. 54, 659-667. doi:10.1292/jvms.54.659.
50. Vila, C., Savolainen, P., Maldonado, J. E., Amorim, I. R., Rice, J. E., Honeycutt, R. L., et al. (1997). Multiple and ancient origins of the domestic dog. Science 276, 1687-1689. doi:10.1126/science.276.5319.1687.
51. Villemagne, V. L., Klunk, W. E., Mathis, C. A., Rowe, C. C., Brooks, D. J., Hyman, B. T., et al. (2012). Abeta Imaging: feasible, pertinent, and vital to progress in Alzheimer's disease. Eur. J. Nucl. Med. Mol. Imaging 39, 209-219. doi:10.1007/s00259-011-2045-0.
52. Watanabe, H., Andersen, F., Simonsen, C. Z., Evans, S. M., Gjedde, A., and Cumming, P. (2001). MR-based statistical atlas of the Gottingen minipig brain. Neuroimage 14, 1089-1096. doi:10.1006/nimg.2001.0910.
53. Watanabe, R., and Duchen, L. W. (1993). Cerebral amyloid in human prion disease. Neuropathol. Appl. Neurobiol. 19, 253-260. doi:10.1111/j.1365-2990.1993.tb00435.x.
54. Yu, C. H., Song, G. S., Yhee, J. Y., Kim, J. H., Im, K. S., Nho, W. G., et al. (2011). Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction. J. Comp. Pathol. 145, 45-58. doi:10.1016/j.jcpa.2010.11.004.